Literature DB >> 4105942

Site of infection in acute urinary-tract infection in general practice.

K F Fairley, N E Carson, R C Gutch, P Leighton, A D Grounds, E C Laird, P H McCallum, R L Sleeman, C M O'Keefe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4105942     DOI： 10.1016/s0140-6736(71)80066-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  42 in total

1.  Diagnostics and categories of patients.

Authors:  A J Schaeffer
Journal:  Infection       Date:  1992       Impact factor: 3.553

2.  Clinical evaluation of the effect of cefuroxime in patients with pyelonephritis and osteomyelitis.

Authors:  W Graninger; H Pichler; K D Mulac; M Bohm; K H Spitzy
Journal:  Proc R Soc Med       Date:  1977

3.  Cefuroxime in chronic and acute cystitis.

Authors:  L B Nilsson; J D Price
Journal:  Proc R Soc Med       Date:  1977

4.  Antibody coated bacteria in urine of patients with recent spinal injury.

Authors:  A Galloway; H T Green; K K Menon; B P Gardner; S Pemberton; K R Krishnan
Journal:  J Clin Pathol       Date:  1990-11       Impact factor: 3.411

5.  Treatment of urinary tract infection with a single dose of trimethoprim-sulfamethoxazole.

Authors:  R R Bailey; G D Abbott
Journal:  Can Med Assoc J       Date:  1978-08-26       Impact factor: 8.262

6.  Correlation between anti-Proteus antibodies and isolation rates of P. mirabilis in rheumatoid arthritis.

Authors:  C Wilson; A Thakore; D Isenberg; A Ebringer
Journal:  Rheumatol Int       Date:  1997       Impact factor: 2.631

7.  The potential impact of biomarker-guided triage decisions for patients with urinary tract infections.

Authors:  A Litke; R Bossart; K Regez; U Schild; M Guglielmetti; A Conca; P Schäfer; B Reutlinger; B Mueller; W C Albrich
Journal:  Infection       Date:  2013-02-24       Impact factor: 3.553

8.  Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis.

Authors:  Xin Li; C Virginia Lockatell; David E Johnson; M Chelsea Lane; John W Warren; Harry L T Mobley
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

9.  Correlation between uropathogenic properties of Escherichia coli from urinary tract infections and the antibody-coated bacteria test and comparison with faecal strains.

Authors:  H J Brooks; B A Benseman; J Peck; K A Bettelheim
Journal:  J Hyg (Lond)       Date:  1981-08

10.  Proteus mirabilis ZapA metalloprotease degrades a broad spectrum of substrates, including antimicrobial peptides.

Authors:  Robert Belas; Jim Manos; Rooge Suvanasuthi
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.